Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Pet Scanner Market

ID: MRFR/HC/27720-HCR
128 Pages
Rahul Gotadki
Last Updated: April 06, 2026

Pet Scanner Market Research Report By Technology (X-ray, Ultrasound, Computed Tomography (CT) Scan, Magnetic Resonance Imaging (MRI), Endoscopy), By Application (Diagnosis, Treatment Planning, Surgery Guidance, Monitoring, Research), By Animal Type (Dogs, Cats, Horses, Birds, Exotics), By End-User (Veterinary Hospitals and Clinics, Diagnostic Imaging Centers, Animal Research Institutes, Pet Owners) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Pet Scanner Market Infographic
Purchase Options
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Healthcare, BY Technology (USD Billion)
  49.     4.1.1 X-ray
  50.     4.1.2 Ultrasound
  51.     4.1.3 Computed Tomography (CT) Scan
  52.     4.1.4 Magnetic Resonance Imaging (MRI)
  53.     4.1.5 Endoscopy
  54.   4.2 Healthcare, BY Application (USD Billion)
  55.     4.2.1 Diagnosis
  56.     4.2.2 Treatment Planning
  57.     4.2.3 Surgery Guidance
  58.     4.2.4 Monitoring
  59.     4.2.5 Research
  60.   4.3 Healthcare, BY Animal Type (USD Billion)
  61.     4.3.1 Dogs
  62.     4.3.2 Cats
  63.     4.3.3 Horses
  64.     4.3.4 Birds
  65.     4.3.5 Exotics
  66.   4.4 Healthcare, BY End-User (USD Billion)
  67.     4.4.1 Veterinary Hospitals and Clinics
  68.     4.4.2 Diagnostic Imaging Centers
  69.     4.4.3 Animal Research Institutes
  70.     4.4.4 Pet Owners
  71.   4.5 Healthcare, BY Region (USD Billion)
  72.     4.5.1 North America
  73.       4.5.1.1 US
  74.       4.5.1.2 Canada
  75.     4.5.2 Europe
  76.       4.5.2.1 Germany
  77.       4.5.2.2 UK
  78.       4.5.2.3 France
  79.       4.5.2.4 Russia
  80.       4.5.2.5 Italy
  81.       4.5.2.6 Spain
  82.       4.5.2.7 Rest of Europe
  83.     4.5.3 APAC
  84.       4.5.3.1 China
  85.       4.5.3.2 India
  86.       4.5.3.3 Japan
  87.       4.5.3.4 South Korea
  88.       4.5.3.5 Malaysia
  89.       4.5.3.6 Thailand
  90.       4.5.3.7 Indonesia
  91.       4.5.3.8 Rest of APAC
  92.     4.5.4 South America
  93.       4.5.4.1 Brazil
  94.       4.5.4.2 Mexico
  95.       4.5.4.3 Argentina
  96.       4.5.4.4 Rest of South America
  97.     4.5.5 MEA
  98.       4.5.5.1 GCC Countries
  99.       4.5.5.2 South Africa
  100.       4.5.5.3 Rest of MEA
  101. 5 SECTION V: COMPETITIVE ANALYSIS
  102.   5.1 Competitive Landscape
  103.     5.1.1 Overview
  104.     5.1.2 Competitive Analysis
  105.     5.1.3 Market share Analysis
  106.     5.1.4 Major Growth Strategy in the Healthcare
  107.     5.1.5 Competitive Benchmarking
  108.     5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  109.     5.1.7 Key developments and growth strategies
  110.       5.1.7.1 New Product Launch/Service Deployment
  111.       5.1.7.2 Merger & Acquisitions
  112.       5.1.7.3 Joint Ventures
  113.     5.1.8 Major Players Financial Matrix
  114.       5.1.8.1 Sales and Operating Income
  115.       5.1.8.2 Major Players R&D Expenditure. 2023
  116.   5.2 Company Profiles
  117.     5.2.1 Idexx Laboratories (US)
  118.       5.2.1.1 Financial Overview
  119.       5.2.1.2 Products Offered
  120.       5.2.1.3 Key Developments
  121.       5.2.1.4 SWOT Analysis
  122.       5.2.1.5 Key Strategies
  123.     5.2.2 Siemens Healthineers (DE)
  124.       5.2.2.1 Financial Overview
  125.       5.2.2.2 Products Offered
  126.       5.2.2.3 Key Developments
  127.       5.2.2.4 SWOT Analysis
  128.       5.2.2.5 Key Strategies
  129.     5.2.3 GE Healthcare (US)
  130.       5.2.3.1 Financial Overview
  131.       5.2.3.2 Products Offered
  132.       5.2.3.3 Key Developments
  133.       5.2.3.4 SWOT Analysis
  134.       5.2.3.5 Key Strategies
  135.     5.2.4 Philips Healthcare (NL)
  136.       5.2.4.1 Financial Overview
  137.       5.2.4.2 Products Offered
  138.       5.2.4.3 Key Developments
  139.       5.2.4.4 SWOT Analysis
  140.       5.2.4.5 Key Strategies
  141.     5.2.5 Canon Medical Systems (JP)
  142.       5.2.5.1 Financial Overview
  143.       5.2.5.2 Products Offered
  144.       5.2.5.3 Key Developments
  145.       5.2.5.4 SWOT Analysis
  146.       5.2.5.5 Key Strategies
  147.     5.2.6 Fujifilm Holdings Corporation (JP)
  148.       5.2.6.1 Financial Overview
  149.       5.2.6.2 Products Offered
  150.       5.2.6.3 Key Developments
  151.       5.2.6.4 SWOT Analysis
  152.       5.2.6.5 Key Strategies
  153.     5.2.7 Agfa-Gevaert Group (BE)
  154.       5.2.7.1 Financial Overview
  155.       5.2.7.2 Products Offered
  156.       5.2.7.3 Key Developments
  157.       5.2.7.4 SWOT Analysis
  158.       5.2.7.5 Key Strategies
  159.     5.2.8 Mindray Medical International Limited (CN)
  160.       5.2.8.1 Financial Overview
  161.       5.2.8.2 Products Offered
  162.       5.2.8.3 Key Developments
  163.       5.2.8.4 SWOT Analysis
  164.       5.2.8.5 Key Strategies
  165.   5.3 Appendix
  166.     5.3.1 References
  167.     5.3.2 Related Reports
  168. 6 LIST OF FIGURES
  169.   6.1 MARKET SYNOPSIS
  170.   6.2 NORTH AMERICA MARKET ANALYSIS
  171.   6.3 US MARKET ANALYSIS BY TECHNOLOGY
  172.   6.4 US MARKET ANALYSIS BY APPLICATION
  173.   6.5 US MARKET ANALYSIS BY ANIMAL TYPE
  174.   6.6 US MARKET ANALYSIS BY END-USER
  175.   6.7 CANADA MARKET ANALYSIS BY TECHNOLOGY
  176.   6.8 CANADA MARKET ANALYSIS BY APPLICATION
  177.   6.9 CANADA MARKET ANALYSIS BY ANIMAL TYPE
  178.   6.10 CANADA MARKET ANALYSIS BY END-USER
  179.   6.11 EUROPE MARKET ANALYSIS
  180.   6.12 GERMANY MARKET ANALYSIS BY TECHNOLOGY
  181.   6.13 GERMANY MARKET ANALYSIS BY APPLICATION
  182.   6.14 GERMANY MARKET ANALYSIS BY ANIMAL TYPE
  183.   6.15 GERMANY MARKET ANALYSIS BY END-USER
  184.   6.16 UK MARKET ANALYSIS BY TECHNOLOGY
  185.   6.17 UK MARKET ANALYSIS BY APPLICATION
  186.   6.18 UK MARKET ANALYSIS BY ANIMAL TYPE
  187.   6.19 UK MARKET ANALYSIS BY END-USER
  188.   6.20 FRANCE MARKET ANALYSIS BY TECHNOLOGY
  189.   6.21 FRANCE MARKET ANALYSIS BY APPLICATION
  190.   6.22 FRANCE MARKET ANALYSIS BY ANIMAL TYPE
  191.   6.23 FRANCE MARKET ANALYSIS BY END-USER
  192.   6.24 RUSSIA MARKET ANALYSIS BY TECHNOLOGY
  193.   6.25 RUSSIA MARKET ANALYSIS BY APPLICATION
  194.   6.26 RUSSIA MARKET ANALYSIS BY ANIMAL TYPE
  195.   6.27 RUSSIA MARKET ANALYSIS BY END-USER
  196.   6.28 ITALY MARKET ANALYSIS BY TECHNOLOGY
  197.   6.29 ITALY MARKET ANALYSIS BY APPLICATION
  198.   6.30 ITALY MARKET ANALYSIS BY ANIMAL TYPE
  199.   6.31 ITALY MARKET ANALYSIS BY END-USER
  200.   6.32 SPAIN MARKET ANALYSIS BY TECHNOLOGY
  201.   6.33 SPAIN MARKET ANALYSIS BY APPLICATION
  202.   6.34 SPAIN MARKET ANALYSIS BY ANIMAL TYPE
  203.   6.35 SPAIN MARKET ANALYSIS BY END-USER
  204.   6.36 REST OF EUROPE MARKET ANALYSIS BY TECHNOLOGY
  205.   6.37 REST OF EUROPE MARKET ANALYSIS BY APPLICATION
  206.   6.38 REST OF EUROPE MARKET ANALYSIS BY ANIMAL TYPE
  207.   6.39 REST OF EUROPE MARKET ANALYSIS BY END-USER
  208.   6.40 APAC MARKET ANALYSIS
  209.   6.41 CHINA MARKET ANALYSIS BY TECHNOLOGY
  210.   6.42 CHINA MARKET ANALYSIS BY APPLICATION
  211.   6.43 CHINA MARKET ANALYSIS BY ANIMAL TYPE
  212.   6.44 CHINA MARKET ANALYSIS BY END-USER
  213.   6.45 INDIA MARKET ANALYSIS BY TECHNOLOGY
  214.   6.46 INDIA MARKET ANALYSIS BY APPLICATION
  215.   6.47 INDIA MARKET ANALYSIS BY ANIMAL TYPE
  216.   6.48 INDIA MARKET ANALYSIS BY END-USER
  217.   6.49 JAPAN MARKET ANALYSIS BY TECHNOLOGY
  218.   6.50 JAPAN MARKET ANALYSIS BY APPLICATION
  219.   6.51 JAPAN MARKET ANALYSIS BY ANIMAL TYPE
  220.   6.52 JAPAN MARKET ANALYSIS BY END-USER
  221.   6.53 SOUTH KOREA MARKET ANALYSIS BY TECHNOLOGY
  222.   6.54 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
  223.   6.55 SOUTH KOREA MARKET ANALYSIS BY ANIMAL TYPE
  224.   6.56 SOUTH KOREA MARKET ANALYSIS BY END-USER
  225.   6.57 MALAYSIA MARKET ANALYSIS BY TECHNOLOGY
  226.   6.58 MALAYSIA MARKET ANALYSIS BY APPLICATION
  227.   6.59 MALAYSIA MARKET ANALYSIS BY ANIMAL TYPE
  228.   6.60 MALAYSIA MARKET ANALYSIS BY END-USER
  229.   6.61 THAILAND MARKET ANALYSIS BY TECHNOLOGY
  230.   6.62 THAILAND MARKET ANALYSIS BY APPLICATION
  231.   6.63 THAILAND MARKET ANALYSIS BY ANIMAL TYPE
  232.   6.64 THAILAND MARKET ANALYSIS BY END-USER
  233.   6.65 INDONESIA MARKET ANALYSIS BY TECHNOLOGY
  234.   6.66 INDONESIA MARKET ANALYSIS BY APPLICATION
  235.   6.67 INDONESIA MARKET ANALYSIS BY ANIMAL TYPE
  236.   6.68 INDONESIA MARKET ANALYSIS BY END-USER
  237.   6.69 REST OF APAC MARKET ANALYSIS BY TECHNOLOGY
  238.   6.70 REST OF APAC MARKET ANALYSIS BY APPLICATION
  239.   6.71 REST OF APAC MARKET ANALYSIS BY ANIMAL TYPE
  240.   6.72 REST OF APAC MARKET ANALYSIS BY END-USER
  241.   6.73 SOUTH AMERICA MARKET ANALYSIS
  242.   6.74 BRAZIL MARKET ANALYSIS BY TECHNOLOGY
  243.   6.75 BRAZIL MARKET ANALYSIS BY APPLICATION
  244.   6.76 BRAZIL MARKET ANALYSIS BY ANIMAL TYPE
  245.   6.77 BRAZIL MARKET ANALYSIS BY END-USER
  246.   6.78 MEXICO MARKET ANALYSIS BY TECHNOLOGY
  247.   6.79 MEXICO MARKET ANALYSIS BY APPLICATION
  248.   6.80 MEXICO MARKET ANALYSIS BY ANIMAL TYPE
  249.   6.81 MEXICO MARKET ANALYSIS BY END-USER
  250.   6.82 ARGENTINA MARKET ANALYSIS BY TECHNOLOGY
  251.   6.83 ARGENTINA MARKET ANALYSIS BY APPLICATION
  252.   6.84 ARGENTINA MARKET ANALYSIS BY ANIMAL TYPE
  253.   6.85 ARGENTINA MARKET ANALYSIS BY END-USER
  254.   6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY TECHNOLOGY
  255.   6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
  256.   6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY ANIMAL TYPE
  257.   6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY END-USER
  258.   6.90 MEA MARKET ANALYSIS
  259.   6.91 GCC COUNTRIES MARKET ANALYSIS BY TECHNOLOGY
  260.   6.92 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION
  261.   6.93 GCC COUNTRIES MARKET ANALYSIS BY ANIMAL TYPE
  262.   6.94 GCC COUNTRIES MARKET ANALYSIS BY END-USER
  263.   6.95 SOUTH AFRICA MARKET ANALYSIS BY TECHNOLOGY
  264.   6.96 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION
  265.   6.97 SOUTH AFRICA MARKET ANALYSIS BY ANIMAL TYPE
  266.   6.98 SOUTH AFRICA MARKET ANALYSIS BY END-USER
  267.   6.99 REST OF MEA MARKET ANALYSIS BY TECHNOLOGY
  268.   6.100 REST OF MEA MARKET ANALYSIS BY APPLICATION
  269.   6.101 REST OF MEA MARKET ANALYSIS BY ANIMAL TYPE
  270.   6.102 REST OF MEA MARKET ANALYSIS BY END-USER
  271.   6.103 KEY BUYING CRITERIA OF HEALTHCARE
  272.   6.104 RESEARCH PROCESS OF MRFR
  273.   6.105 DRO ANALYSIS OF HEALTHCARE
  274.   6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE
  275.   6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
  276.   6.108 SUPPLY / VALUE CHAIN: HEALTHCARE
  277.   6.109 HEALTHCARE, BY TECHNOLOGY, 2024 (% SHARE)
  278.   6.110 HEALTHCARE, BY TECHNOLOGY, 2024 TO 2035 (USD Billion)
  279.   6.111 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
  280.   6.112 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion)
  281.   6.113 HEALTHCARE, BY ANIMAL TYPE, 2024 (% SHARE)
  282.   6.114 HEALTHCARE, BY ANIMAL TYPE, 2024 TO 2035 (USD Billion)
  283.   6.115 HEALTHCARE, BY END-USER, 2024 (% SHARE)
  284.   6.116 HEALTHCARE, BY END-USER, 2024 TO 2035 (USD Billion)
  285.   6.117 BENCHMARKING OF MAJOR COMPETITORS
  286. 7 LIST OF TABLES
  287.   7.1 LIST OF ASSUMPTIONS
  288.     7.1.1
  289.   7.2 North America MARKET SIZE ESTIMATES; FORECAST
  290.     7.2.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  291.     7.2.2 BY APPLICATION, 2025-2035 (USD Billion)
  292.     7.2.3 BY ANIMAL TYPE, 2025-2035 (USD Billion)
  293.     7.2.4 BY END-USER, 2025-2035 (USD Billion)
  294.   7.3 US MARKET SIZE ESTIMATES; FORECAST
  295.     7.3.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  296.     7.3.2 BY APPLICATION, 2025-2035 (USD Billion)
  297.     7.3.3 BY ANIMAL TYPE, 2025-2035 (USD Billion)
  298.     7.3.4 BY END-USER, 2025-2035 (USD Billion)
  299.   7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  300.     7.4.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  301.     7.4.2 BY APPLICATION, 2025-2035 (USD Billion)
  302.     7.4.3 BY ANIMAL TYPE, 2025-2035 (USD Billion)
  303.     7.4.4 BY END-USER, 2025-2035 (USD Billion)
  304.   7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  305.     7.5.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  306.     7.5.2 BY APPLICATION, 2025-2035 (USD Billion)
  307.     7.5.3 BY ANIMAL TYPE, 2025-2035 (USD Billion)
  308.     7.5.4 BY END-USER, 2025-2035 (USD Billion)
  309.   7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  310.     7.6.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  311.     7.6.2 BY APPLICATION, 2025-2035 (USD Billion)
  312.     7.6.3 BY ANIMAL TYPE, 2025-2035 (USD Billion)
  313.     7.6.4 BY END-USER, 2025-2035 (USD Billion)
  314.   7.7 UK MARKET SIZE ESTIMATES; FORECAST
  315.     7.7.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  316.     7.7.2 BY APPLICATION, 2025-2035 (USD Billion)
  317.     7.7.3 BY ANIMAL TYPE, 2025-2035 (USD Billion)
  318.     7.7.4 BY END-USER, 2025-2035 (USD Billion)
  319.   7.8 France MARKET SIZE ESTIMATES; FORECAST
  320.     7.8.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  321.     7.8.2 BY APPLICATION, 2025-2035 (USD Billion)
  322.     7.8.3 BY ANIMAL TYPE, 2025-2035 (USD Billion)
  323.     7.8.4 BY END-USER, 2025-2035 (USD Billion)
  324.   7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  325.     7.9.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  326.     7.9.2 BY APPLICATION, 2025-2035 (USD Billion)
  327.     7.9.3 BY ANIMAL TYPE, 2025-2035 (USD Billion)
  328.     7.9.4 BY END-USER, 2025-2035 (USD Billion)
  329.   7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  330.     7.10.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  331.     7.10.2 BY APPLICATION, 2025-2035 (USD Billion)
  332.     7.10.3 BY ANIMAL TYPE, 2025-2035 (USD Billion)
  333.     7.10.4 BY END-USER, 2025-2035 (USD Billion)
  334.   7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  335.     7.11.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  336.     7.11.2 BY APPLICATION, 2025-2035 (USD Billion)
  337.     7.11.3 BY ANIMAL TYPE, 2025-2035 (USD Billion)
  338.     7.11.4 BY END-USER, 2025-2035 (USD Billion)
  339.   7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  340.     7.12.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  341.     7.12.2 BY APPLICATION, 2025-2035 (USD Billion)
  342.     7.12.3 BY ANIMAL TYPE, 2025-2035 (USD Billion)
  343.     7.12.4 BY END-USER, 2025-2035 (USD Billion)
  344.   7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  345.     7.13.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  346.     7.13.2 BY APPLICATION, 2025-2035 (USD Billion)
  347.     7.13.3 BY ANIMAL TYPE, 2025-2035 (USD Billion)
  348.     7.13.4 BY END-USER, 2025-2035 (USD Billion)
  349.   7.14 China MARKET SIZE ESTIMATES; FORECAST
  350.     7.14.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  351.     7.14.2 BY APPLICATION, 2025-2035 (USD Billion)
  352.     7.14.3 BY ANIMAL TYPE, 2025-2035 (USD Billion)
  353.     7.14.4 BY END-USER, 2025-2035 (USD Billion)
  354.   7.15 India MARKET SIZE ESTIMATES; FORECAST
  355.     7.15.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  356.     7.15.2 BY APPLICATION, 2025-2035 (USD Billion)
  357.     7.15.3 BY ANIMAL TYPE, 2025-2035 (USD Billion)
  358.     7.15.4 BY END-USER, 2025-2035 (USD Billion)
  359.   7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  360.     7.16.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  361.     7.16.2 BY APPLICATION, 2025-2035 (USD Billion)
  362.     7.16.3 BY ANIMAL TYPE, 2025-2035 (USD Billion)
  363.     7.16.4 BY END-USER, 2025-2035 (USD Billion)
  364.   7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  365.     7.17.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  366.     7.17.2 BY APPLICATION, 2025-2035 (USD Billion)
  367.     7.17.3 BY ANIMAL TYPE, 2025-2035 (USD Billion)
  368.     7.17.4 BY END-USER, 2025-2035 (USD Billion)
  369.   7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  370.     7.18.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  371.     7.18.2 BY APPLICATION, 2025-2035 (USD Billion)
  372.     7.18.3 BY ANIMAL TYPE, 2025-2035 (USD Billion)
  373.     7.18.4 BY END-USER, 2025-2035 (USD Billion)
  374.   7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  375.     7.19.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  376.     7.19.2 BY APPLICATION, 2025-2035 (USD Billion)
  377.     7.19.3 BY ANIMAL TYPE, 2025-2035 (USD Billion)
  378.     7.19.4 BY END-USER, 2025-2035 (USD Billion)
  379.   7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  380.     7.20.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  381.     7.20.2 BY APPLICATION, 2025-2035 (USD Billion)
  382.     7.20.3 BY ANIMAL TYPE, 2025-2035 (USD Billion)
  383.     7.20.4 BY END-USER, 2025-2035 (USD Billion)
  384.   7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  385.     7.21.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  386.     7.21.2 BY APPLICATION, 2025-2035 (USD Billion)
  387.     7.21.3 BY ANIMAL TYPE, 2025-2035 (USD Billion)
  388.     7.21.4 BY END-USER, 2025-2035 (USD Billion)
  389.   7.22 South America MARKET SIZE ESTIMATES; FORECAST
  390.     7.22.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  391.     7.22.2 BY APPLICATION, 2025-2035 (USD Billion)
  392.     7.22.3 BY ANIMAL TYPE, 2025-2035 (USD Billion)
  393.     7.22.4 BY END-USER, 2025-2035 (USD Billion)
  394.   7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  395.     7.23.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  396.     7.23.2 BY APPLICATION, 2025-2035 (USD Billion)
  397.     7.23.3 BY ANIMAL TYPE, 2025-2035 (USD Billion)
  398.     7.23.4 BY END-USER, 2025-2035 (USD Billion)
  399.   7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  400.     7.24.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  401.     7.24.2 BY APPLICATION, 2025-2035 (USD Billion)
  402.     7.24.3 BY ANIMAL TYPE, 2025-2035 (USD Billion)
  403.     7.24.4 BY END-USER, 2025-2035 (USD Billion)
  404.   7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  405.     7.25.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  406.     7.25.2 BY APPLICATION, 2025-2035 (USD Billion)
  407.     7.25.3 BY ANIMAL TYPE, 2025-2035 (USD Billion)
  408.     7.25.4 BY END-USER, 2025-2035 (USD Billion)
  409.   7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  410.     7.26.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  411.     7.26.2 BY APPLICATION, 2025-2035 (USD Billion)
  412.     7.26.3 BY ANIMAL TYPE, 2025-2035 (USD Billion)
  413.     7.26.4 BY END-USER, 2025-2035 (USD Billion)
  414.   7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  415.     7.27.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  416.     7.27.2 BY APPLICATION, 2025-2035 (USD Billion)
  417.     7.27.3 BY ANIMAL TYPE, 2025-2035 (USD Billion)
  418.     7.27.4 BY END-USER, 2025-2035 (USD Billion)
  419.   7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  420.     7.28.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  421.     7.28.2 BY APPLICATION, 2025-2035 (USD Billion)
  422.     7.28.3 BY ANIMAL TYPE, 2025-2035 (USD Billion)
  423.     7.28.4 BY END-USER, 2025-2035 (USD Billion)
  424.   7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  425.     7.29.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  426.     7.29.2 BY APPLICATION, 2025-2035 (USD Billion)
  427.     7.29.3 BY ANIMAL TYPE, 2025-2035 (USD Billion)
  428.     7.29.4 BY END-USER, 2025-2035 (USD Billion)
  429.   7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  430.     7.30.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  431.     7.30.2 BY APPLICATION, 2025-2035 (USD Billion)
  432.     7.30.3 BY ANIMAL TYPE, 2025-2035 (USD Billion)
  433.     7.30.4 BY END-USER, 2025-2035 (USD Billion)
  434.   7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  435.     7.31.1
  436.   7.32 ACQUISITION/PARTNERSHIP
  437.     7.32.1

Healthcare Market Segmentation

Healthcare By Technology (USD Billion, 2025-2035)

  • X-ray
  • Ultrasound
  • Computed Tomography (CT) Scan
  • Magnetic Resonance Imaging (MRI)
  • Endoscopy

Healthcare By Application (USD Billion, 2025-2035)

  • Diagnosis
  • Treatment Planning
  • Surgery Guidance
  • Monitoring
  • Research

Healthcare By Animal Type (USD Billion, 2025-2035)

  • Dogs
  • Cats
  • Horses
  • Birds
  • Exotics

Healthcare By End-User (USD Billion, 2025-2035)

  • Veterinary Hospitals and Clinics
  • Diagnostic Imaging Centers
  • Animal Research Institutes
  • Pet Owners

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions